Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...
Labcorp has agreed to acquire select BioReference Health assets from OPKO Health in a transaction that includes $722 million ...
Labcorp has launched the Thrive 5 Health Test that is now offered through a collaboration with Arianna Huffington's behavior ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the ...
Medical Device Network on MSN
Labcorp outlays up to $872m to acquire BioReference’s laboratory assets
Labcorp said the agreement will help to improve access to its own laboratory services.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical company, announced today that they have ...
Headquartered in Burlington, North Carolina, Labcorp Holdings Inc. (LH) operates one of the world’s largest laboratory ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...
BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the first hour ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026 before the market opens on ...
Labcorp has agreed to buy the remaining diagnostic testing operations of OPKO Health's BioReference Health unit in a deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results